Physician profile
William Kaufman
NPI 1710976519
$1,556.15
in general payments reported to CMS, 2019-2025
22 companies · $33.34 in 2025
The $33.34 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $183 · 2021: $301 · 2022: $455 · 2023: $169 · 2024: $170 · 2025: $33.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $338.99 | 2019-2023 | |
| Hologic Sales and Service, LLC | $185.34 | 2020-2024 | Aptima |
| Astellas Pharma US INC | $158.25 | 2019-2024 | Myrbetriq, Veozah |
| Exeltis, USA INC. | $152.30 | 2019-2023 | Slynd |
| Coopersurgical, INC. | $122.67 | 2019-2024 | Paragard T 380a, Summit Doppler |
| Mayne Pharma Commercial LLC | $122.33 | 2021-2024 | |
| Therapeuticsmd, INC. | $94.18 | 2019-2022 | |
| Roche Diagnostics Corporation | $38.15 | 2021 | |
| Pfizer INC. | $37.19 | 2022-2024 | |
| Exact Sciences Corporation | $33.34 | 2025 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $32.55 | 2019-2023 | Injectafer |
| Agile Therapeutics, INC. | $30.00 | 2021 | |
| Vertical Pharmaceuticals, LLC | $28.55 | 2019 | |
| Amag Pharmaceuticals, INC. | $27.70 | 2019 | |
| Evofem Biosciences, INC. | $26.51 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $25.81 | 2019 | |
| Allergan, INC. | $23.41 | 2019-2020 | |
| Sage Therapeutics, LLC | $19.86 | 2024 | |
| Lupin INC. | $16.26 | 2019 | |
| Scynexis, INC. | $14.99 | 2022 | |
| Ascend Therapeutics US, LLC | $14.20 | 2021 | |
| Amgen INC. | $13.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Kaufman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.